Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Trinity Biotech's share price for the quarter that ended in Sep. 2023 was $3.6755. Trinity Biotech's Shares Outstanding (EOP) for the quarter that ended in Sep. 2023 was 7.64 Mil. Therefore, Trinity Biotech's market cap for the quarter that ended in Sep. 2023 was $28.09 Mil.
Trinity Biotech's quarterly market cap
increased
from Mar. 2023 ($35.92 Mil) to Jun. 2023 ($36.34 Mil) but then
declined
from Jun. 2023 ($36.34 Mil) to Sep. 2023 ($28.09 Mil).
Trinity Biotech's annual market cap
declined
from Dec. 2020 ($79.64 Mil) to Dec. 2021 ($29.89 Mil) but then
increased
from Dec. 2021 ($29.89 Mil) to Dec. 2022 ($37.73 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Trinity Biotech's Enterprise Value for Today is $74.74 Mil.
Trinity Biotech Market Cap Historical Data
The historical data trend for Trinity Biotech's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Trinity Biotech's Market Cap
For the Diagnostics & Research subindustry, Trinity Biotech's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Trinity Biotech's Market Cap Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Trinity Biotech's Market Cap distribution charts can be found below:
* The bar in red indicates where Trinity Biotech's Market Cap falls into.
Trinity Biotech Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Trinity Biotech's Market Cap for the fiscal year that ended in Dec. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Trinity Biotech (NAS:TRIB) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Trinity Biotech Market Cap Related Terms
Thank you for viewing the detailed overview of Trinity Biotech's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Trinity Biotech (Trinity Biotech) Business Description
Trinity Biotech PLC is in the business of development, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point of care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Premier, Immublot, EZ, Capita, and others. Geographically, it has two segments namely the Americas, and Rest of World - Ireland of which it derives a majority of its revenues from the Americas segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TRIB has been successfully added to your 